289 related articles for article (PubMed ID: 21801115)
1. Combined use of botulinum toxin type A and B for forehead rhytides: a randomized, double-blind, split-face study.
Choi JW; Youn CS; An HT; Yoo JY; Na JI; Park KC; Youn SW; Huh CH
J Dermatolog Treat; 2013 Apr; 24(2):126-32. PubMed ID: 21801115
[TBL] [Abstract][Full Text] [Related]
2. Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial.
Dubina M; Tung R; Bolotin D; Mahoney AM; Tayebi B; Sato M; Mulinari-Brenner F; Jones T; West DP; Poon E; Nodzenski M; Alam M
J Cosmet Dermatol; 2013 Dec; 12(4):261-6. PubMed ID: 24305424
[TBL] [Abstract][Full Text] [Related]
3. A prospective, double-blind, randomized, parallel- group, dose-ranging study of botulinum toxin type a in female subjects with horizontal forehead rhytides.
Carruthers A; Carruthers J; Cohen J
Dermatol Surg; 2003 May; 29(5):461-7. PubMed ID: 12752512
[TBL] [Abstract][Full Text] [Related]
4. A four-month randomized, double-blind evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types V and VI.
Grimes PE; Shabazz D
Dermatol Surg; 2009 Mar; 35(3):429-35; discussion 435-6. PubMed ID: 19250310
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized comparison of onabotulinumtoxinA (Botox) and abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles.
Michaels BM; Csank GA; Ryb GE; Eko FN; Rubin A
Aesthet Surg J; 2012 Jan; 32(1):96-102. PubMed ID: 22231417
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
Pappert EJ; Germanson T;
Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion.
Flynn TC; Clark RE
Dermatol Surg; 2003 May; 29(5):519-22; discussion 522. PubMed ID: 12752521
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians.
Choi SY; Koh YG; Lee YW; Son HS; Yoon YN; Kim G; Won C; Cho H; Son JS; Kim EK; Kim BJ
J Dermatolog Treat; 2024 Dec; 35(1):2359511. PubMed ID: 38880494
[TBL] [Abstract][Full Text] [Related]
9. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety.
Brandt F; Swanson N; Baumann L; Huber B
Dermatol Surg; 2009 Dec; 35(12):1893-901. PubMed ID: 19549186
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248
[TBL] [Abstract][Full Text] [Related]
11. Alteration of Skin Mechanical Properties in Patients Undergoing Botulinum Toxin Type A Injections of Forehead Rhytides.
Min P; Zhang Z; Grassetti L; Perdanasari AT; Torresetti M; Pu Z; Zhang Y; Han S; Marsili R; Zhang YX; di Benedetto G; Lazzeri D
Aesthetic Plast Surg; 2016 Jun; 40(3):410-20. PubMed ID: 26944891
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin A.
Lee JH; Park JH; Lee SK; Han KH; Kim SD; Yoon CS; Park JY; Lee JH; Yang JM; Lee JH
J Dermatolog Treat; 2014 Aug; 25(4):326-30. PubMed ID: 23356833
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
Dessy LA; Fallico N; Mazzocchi M; Scuderi N
Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
Alster TS; Lupton JR
Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
[TBL] [Abstract][Full Text] [Related]
16. RimabotulinumtoxinB vs. onabotulinumtoxinA for the treatment of forehead lines: an evaluator-blind, randomized, pilot study.
Lee DH; Kang SM; Feneran A; Youn CS; Kim JK; Cho S; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e1-7. PubMed ID: 23030660
[TBL] [Abstract][Full Text] [Related]
17. Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?
Kaufman-Janette J; Cox SE; Dayan S; Joseph J
Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357966
[TBL] [Abstract][Full Text] [Related]
18. Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides.
Matarasso SL
Dermatol Surg; 2003 Jan; 29(1):7-13; discussion 13. PubMed ID: 12534505
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure.
Dressler D; Bigalke H; Benecke R
J Neurol; 2003 Aug; 250(8):967-9. PubMed ID: 12928917
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Botulinum Toxin Type A for Treatment of Glabellar Lines: A Network Meta-Analysis of Randomized Controlled Trials.
Li X; Sui C; Xia X; Chen X
Aesthetic Plast Surg; 2023 Feb; 47(1):365-377. PubMed ID: 36097079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
